Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Trigger for platelet transfusion.

P Rebulla1

  • 1Centro Trasfusionale e di Immunologia dei Trapianti, IRCCS Ospedale Maggiore, Milano, Italy. prebulla@libero.it

Vox Sanguinis
|August 12, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A miRNA Signature in Human Cord Blood Stem and Progenitor Cells as Potential Biomarker of Specific Acute Myeloid Leukemia Subtypes.

Journal of cellular physiology·2014
Same author

Prevention of transfusion-transmitted cytomegalovirus (CMV) infection: Standards of care.

Vox sanguinis·2014
Same author

Should DEHP be eliminated in blood bags?

Vox sanguinis·2013
Same author

The use of the electronic (computer) cross-match.

Vox sanguinis·2013
Same author

Donor selection and release criteria of cellular therapy products.

Vox sanguinis·2012
Same author

Prophylactic platelet transfusions.

Vox sanguinis·2012
Same journal

In vitro evaluation of apheresis platelet and plasma products collected and stored in non-DEHP disposable sets.

Vox sanguinis·2026
Same journal

Survey of national and regional rare donor programmes regarding Immunoglobulin A deficiency.

Vox sanguinis·2026
Same journal

Fibrinogen recovery in cryoprecipitate prepared from thawed plasma stored for 5 days post-thaw.

Vox sanguinis·2026
Same journal

Abstracts of the 39th International Congress of the ISBT, Kuala Lumpur, Malaysia, 20-24 June 2026.

Vox sanguinis·2026
Same journal

Development and improvement of Chinese Haemovigilance Network from 2018 to 2023.

Vox sanguinis·2026
Same journal

Marginal anaemia and perioperative transfusion in female patients undergoing cardiac surgery.

Vox sanguinis·2026
See all related articles

The current guideline recommends a platelet transfusion trigger of 10,000 platelets/µL for stable oncohematology patients. Higher thresholds are advised for specific conditions and surgical settings, ensuring patient safety.

Area of Science:

  • Hematology
  • Transfusion Medicine
  • Oncology

Background:

  • Platelet transfusion triggers guide prophylactic platelet administration.
  • Current consensus supports a 10,000 platelets/µL trigger for stable oncohematology patients.
  • Higher triggers are necessary for specific clinical conditions and patient populations.

Purpose of the Study:

  • To review the evidence and consensus on platelet transfusion triggers.
  • To highlight the implications of lowering the trigger to 10,000 platelets/µL.
  • To address the differing recommendations for surgical patients.

Main Methods:

  • Review of scientific literature and clinical guidelines.
  • Analysis of randomized clinical trials and observational studies.

Related Experiment Videos

  • Discussion of automated hematology counter performance at low platelet counts.
  • Main Results:

    • A 10,000 platelets/µL trigger is considered safe for monitored oncohematology patients.
    • Specific conditions (fever, infection, splenomegaly, etc.) necessitate higher triggers.
    • Surgical patients typically require higher platelet counts (50,000-100,000/µL).

    Conclusions:

    • The 10,000 platelets/µL trigger requires robust platelet availability and clinician-specialist cooperation.
    • Understanding automated counter precision is crucial for low platelet counts.
    • Evidence for surgical settings is limited, necessitating higher perioperative thresholds.